新辅助化疗治疗宫颈癌35例临床疗效观察  

Clinical effect observation of neoadjuvant chemotherapy in treatment of cervical cancer 35 cases

作　　者：徐海波[1] 刘蓉[1] 

机构地区：[1]南通大学附属肿瘤医院妇产科,江苏南通226361

出　　处：《医药论坛杂志》2011年第22期14-15,共2页Journal of Medical Forum

摘　　要：目的观察并探讨术前新辅助化疗对宫颈癌的临床疗效。方法选取南通大学附属肿瘤医院符合标准的35例宫颈癌患者作为观察研究对象,全部病例术前均予采用紫杉醇、顺铂联合方案(TP)化疗2个疗程后行广泛性子宫切除术与盆腔淋巴结清扫术,观察近期疗效。结果术前新辅助化疗可提高手术切除率,改善症状。临床近期有效率74.3%,手术切除率达100%。结论宫颈癌新辅助化疗可以缩小肿瘤,提高手术的治疗效果。Objective To observe and explore the clinical effect of neoadjuvant chemotherapy in treatment of cervical cancer.Methods The hospital standard of 35 cases of cervical cancer as the observation study,all patients preoperative herein are the use of cisplatin,vinblastine,adriamycin chemotherapy,2 treatment and uterine resection and pelvic lymph node dissection,observation of short-term effect.Results Preoperative neoadjuvant chemotherapy can improve the resection rate and improve symptoms.Recent clinical efficiency of 74.3%,surgical resection was 100%.Conclusions The cervical cancer neoadjuvant chemotherapy can shrink tumors and improve the effect of surgical treatment.

关 键 词：宫颈癌 新辅助化疗 手术治疗 

分 类 号：R737.33[医药卫生—肿瘤]